cell
provid
natur
bridg
innat
adapt
immun
rapidli
potent
respond
pathogen
infect
mucos
tissu
promin
induc
tuberculosi
tb
infect
bacillu
calmett
bcg
vaccin
mycobacteriumexpand
cell
repres
subset
phosphoantigen
isopentenyl
pyrophosph
ipp
e
hmbpp
respons
cell
express
oligoclon
set
cell
receptor
tcr
sequenc
effici
recogn
inhibit
intracellular
mycobacterium
tuberculosi
infect
base
premis
search
tuberculosi
antigen
specif
capabl
induc
uniqu
subset
mycobacteriumprotect
cell
screen
strategi
includ
identif
tuberculosi
fraction
expand
cell
biolog
function
capabl
inhibit
intracellular
mycobacteri
replic
chemic
treatment
tuberculosi
wholecel
lysat
mtbwl
rule
protein
nucleic
acid
nonpolar
lipid
tuberculosi
antigen
induc
protect
cell
mild
acid
hydrolysi
transform
complex
carbohydr
monomer
residu
abrog
specif
activ
tuberculosi
wholecel
lysat
suggest
polysaccharid
requir
biolog
activ
extract
mtbwl
chloroformmethanolwat
result
polar
lipid
fraction
highli
enrich
specif
activ
activ
enrich
silica
gel
chromatographi
combin
mass
spectrometri
nuclear
magnet
reson
analysi
bioactiv
fraction
indic
lipopolysaccharid
mglp
predomin
compon
present
activ
fraction
result
import
implic
develop
new
immunotherapeut
approach
prevent
treatment
tb
base
premis
search
tuberculosi
antigen
specif
capabl
induc
uniqu
subset
mycobacteriumprotect
cell
screen
strategi
includ
identif
tuberculosi
fraction
expand
cell
biolog
function
capabl
inhibit
intracellular
mycobacteri
replic
chemic
treatment
tuberculosi
wholecel
lysat
mtbwl
rule
protein
nucleic
acid
nonpolar
lipid
tuberculosi
antigen
induc
protect
cell
mild
acid
hydrolysi
transform
complex
carbohydr
monomer
residu
abrog
specif
activ
tuberculosi
wholecel
lysat
suggest
polysaccharid
requir
biolog
activ
extract
mtbwl
chloroformmethanolwat
result
polar
lipid
fraction
highli
enrich
specif
activ
activ
enrich
silica
gel
chromatographi
combin
mass
spectrometri
nuclear
magnet
reson
analysi
bioactiv
fraction
indic
lipopolysaccharid
mglp
predomin
compon
present
activ
fraction
result
import
implic
develop
new
immunotherapeut
approach
prevent
treatment
tb
uberculosi
tb
caus
mycobacterium
tuberculosi
remain
global
health
crisi
becom
increasingli
preval
deadli
result
emerg
multidrugresist
mdr
tb
hivaid
pandem
given
evid
tb
patient
develop
immun
dysfunct
immun
intervent
regul
counterproduct
inflamm
andor
enhanc
antitb
immun
respons
may
benefici
clinic
treatment
tb
mdr
tb
immun
therapi
long
consid
attract
adjunct
clinic
treatment
tb
especi
mdr
tb
success
immunotherapeut
modal
identifi
fact
littl
known
human
tb
immun
except
human
cell
gener
believ
import
tb
resist
accumul
evid
suggest
cell
play
critic
role
tb
protect
immun
respons
may
key
earli
respond
acut
infect
bridg
innat
adapt
immun
unlik
convent
major
histocompat
complex
mhc
restrict
cell
human
nonhuman
primat
cell
stimul
expand
nonmhcrestrict
way
small
phosphoryl
nonproteinac
antigen
eg
ipp
brhpp
hmbpp
see
natur
phosphoantigen
includ
prenyl
pyrophosph
synthet
precursor
lipid
steroid
biosynthesi
phosphoryl
nucleotid
secret
increas
amount
byproduct
infect
pathogen
host
cell
alter
infect
reactiv
cell
nonmhcrestrict
nonvari
tuberculosi
ligand
provid
potenti
advantag
univers
subject
respons
regardless
complex
hla
express
pattern
human
popul
specif
tuberculosi
earlier
biochem
analysi
identifi
molecul
tuberculosi
lysat
term
stimul
prolifer
human
cell
clone
tubag
compound
shown
activ
nanomolar
rang
ie
bioactiv
higher
isopentenyl
pyrophosph
ipp
thu
suggest
molecul
could
account
cellstimul
activ
recov
mycobacteria
shortli
isol
first
cell
antigen
structur
identifi
ipp
metabolit
organ
use
synthes
isoprenoid
compound
prenyl
pyrophosph
famili
phosphoantigen
includ
isom
conjug
concatem
ipp
exchang
pyrophosph
moieti
singl
phosphat
moieti
significantli
reduc
abil
isoprenoid
stimul
expans
cell
contrast
alter
alkyl
chain
conjug
utp
minor
influenc
potenc
phosphoantigen
expand
cell
suggest
ipp
natur
occur
prenyl
pyrophosph
capabl
stimul
cell
expans
howev
concentr
ipp
present
bacteri
lysat
suffici
stimul
cell
expans
potent
natur
phosphoantigen
describ
far
phosphoryl
intermedi
produc
eubacteria
eukaryot
organ
call
e
hmbpp
also
known
hdmapp
hydroxydimethylallylpyrophosph
compound
potent
stimul
cell
ipp
addit
synthet
bromohydrin
pyrophosph
brhpp
strong
activ
cell
test
tumor
immunotherapi
vaccin
compon
demonstr
us
previous
live
mycobacteria
purifi
prenyl
pyrophosph
induc
similar
expans
cell
capabl
gamma
interferon
product
cytolyt
activ
cell
stimul
ipp
brhpp
hmbpp
fail
inhibit
intracellular
mycobacteri
growth
even
concomit
stimul
tolllik
receptor
tlr
ligand
found
cell
capabl
inhibit
intracellular
tuberculosi
growth
repres
subset
phosphoantigen
ipp
hmbpp
respons
cell
protect
subset
express
oligoclon
set
cell
receptor
tcr
sequenc
capabl
pathogenspecif
recognit
tuberculosisinfect
human
macrophag
hypothes
high
potenc
natur
hmbpp
phosphoantigen
present
mycobacteri
extract
could
obscur
detect
protect
cell
subset
also
hypothes
live
mycobacteria
express
antigen
ag
previous
identifi
phosphoantigen
requir
induc
subset
cell
protect
tuberculosi
intracellular
replic
natur
tbspecif
cell
ag
must
identifi
purifi
use
optim
immunotherapi
vaccin
target
protect
subset
cell
studi
establish
novel
strategi
fraction
biochem
treat
mycobacteri
lysat
identifi
molecul
respons
expans
cell
capabl
inhibit
intracellular
mycobacteri
growth
first
rule
protein
nucleic
acid
apolar
lipid
basic
separ
enzymat
digest
mild
acid
hydrolysi
digest
complex
carbohydr
structur
largest
effect
specif
activ
fraction
deriv
chloroformmethanolwat
extract
tuberculosi
cell
primarili
consist
glycolipid
carbohydr
antigen
fraction
test
abil
clonal
expand
human
cell
inhibitori
activ
intracellular
mycobacteria
highest
biolog
specif
activ
sa
found
polar
fraction
elut
silica
column
methanol
fraction
use
size
exclus
column
chromatographi
column
util
demonstr
highest
activ
earlyelut
fraction
complex
antigen
activ
fraction
analyz
via
matrixassist
laser
desorpt
ionizationtim
flight
malditof
mass
spectrometri
ms
thinlay
chromatographi
tlc
h
nuclear
magnet
reson
nmr
ga
chromatographymass
spectrometri
gcm
analys
reveal
methylglucos
lipopolysaccharid
mglp
predomin
compon
present
highli
activ
fraction
identif
purif
synthesi
novel
mycobacteri
lipid
compon
induc
tb
protect
cell
may
result
new
immun
intervent
strategi
sensit
drugresist
tb
human
peripher
blood
mononuclear
cell
pbmc
obtain
healthi
tuberculin
skin
testposit
donor
leukapheresi
monocyt
purifi
pbmc
plastic
adher
base
uniqu
adhes
properti
monocyt
macrophag
among
pbmc
popul
media
reagent
mammalian
cell
cultur
experi
complet
mycobacterium
bovi
bcg
stock
prepar
report
previous
wholecel
lysat
tuberculosi
mtbwl
obtain
bei
resourc
solubl
pyrophosph
hmbpp
echelon
bioscienc
salt
lake
citi
ut
use
stimul
cell
control
inhibit
assay
interleukin
hoffmannlaroch
inc
basel
switzerland
use
expand
cell
peridinin
chlorophyl
protein
percp
clone
tcr
fluorescein
isothiocyan
fitc
clone
tcr
phycoerythrin
pe
clone
clone
clone
clone
antitumor
necrosi
factor
alpha
antigranzym
antigzma
bd
bioscienc
guava
viacount
flex
reagent
millipor
use
accur
count
discrimin
viabl
nonviabl
cell
antigenexpand
cell
chemic
biochem
separ
obtain
acro
organ
silica
gel
sigmaaldrich
chloroform
methanol
alkalin
phosphatas
ap
obtain
fisher
scientif
bp
purif
character
novel
lipid
compon
tuberculosi
total
lipid
extract
gammairradi
lyophil
cell
chcl
ch
ohh
vol
volvol
h
room
temperatur
thorough
mix
supernat
dri
nitrogen
drycel
extract
g
g
carbohydr
content
use
coat
silica
gel
g
load
dri
silica
gel
column
g
column
elut
chcl
ml
volvol
meoh
chcl
ml
volvol
meoh
chcl
ml
volvol
meoh
chcl
ml
volvol
meoh
chcl
ml
meoh
ml
quick
test
reveal
meohchcl
fraction
carbohydr
rich
carbohydr
content
approxim
mg
meoh
mg
meoh
mg
meoh
mg
meoh
aliquot
l
fraction
taken
alditol
acet
assay
perform
use
gcm
treatment
mycobacteri
lysat
reduct
alkyl
lysat
suspend
mgml
guanidin
hydrochlorid
trishcl
ph
fresh
dithiothreitol
dtt
ad
final
concentr
mm
sampl
incub
stir
h
fresh
mm
iodoacetamid
iaa
ad
final
concentr
mm
sampl
incub
min
sampl
dialyz
mm
ammonium
bicarbon
remov
excess
dtt
iaa
ii
delipid
lysat
delipid
two
extract
chloroformmethanol
solut
h
follow
centrifug
g
h
organ
layer
remov
remain
pellet
extract
two
addit
time
use
solut
chloroformmethanolwat
centrifug
final
insolubl
pellet
use
total
delipid
mycobacteri
fraction
dri
nitrogen
remov
residu
solvent
iii
dnase
rnase
treatment
lysat
suspend
trishcl
buffer
contain
mm
magnesium
chlorid
dnase
rnase
ad
final
concentr
mgml
sampl
incub
h
enzym
inactiv
multipl
freezethaw
cycl
iv
pronas
digest
lysat
suspend
mgml
ammonium
bicarbon
pronas
stock
solut
mgml
ammonium
bicarbon
ad
final
concentr
mgml
give
enzymetoprotein
ratio
sampl
incub
overnight
pronas
inactiv
multipl
freezethaw
cycl
peptid
separ
undigest
materi
pass
membran
cutoff
v
trypsin
digest
lysat
suspend
mgml
ammonium
bicarbon
trypsin
stock
solut
mgml
ammonium
bicarbon
ad
final
concentr
mgml
give
enzymetoprotein
ratio
sampl
incub
overnight
trypsin
inactiv
addit
trifluoroacet
acid
tfa
peptid
separ
undigest
materi
pass
membran
cutoff
follow
dri
speedvac
remov
residu
tfa
vi
mild
acid
hydrolysi
lysat
suspend
mgml
trifluoroacet
acid
incub
h
cool
dri
speedvac
dri
materi
suspend
water
vii
base
hydrolysi
lysat
suspend
mgml
trishcl
ph
naoh
ad
sampl
incub
h
tfa
solut
ad
final
concentr
stop
reaction
sampl
dri
speedvac
dri
materi
suspend
water
resolut
meoh
fraction
mglp
enrich
dri
meoh
fraction
mg
carbohydr
stoichiometr
weight
dissolv
water
ml
load
onto
size
exclus
column
cm
cm
elut
water
flow
rate
mlmin
fraction
ml
per
min
collect
quick
assay
perform
identifi
carbohydrateenrich
ml
fraction
everi
three
consecut
fraction
pool
monosaccharid
composit
determin
use
gcm
analysi
reveal
fraction
pure
enrich
mglp
content
yield
g
malditof
ms
purifi
silica
gel
column
fraction
l
mix
l
acid
dhb
mgml
tfa
mixtur
allow
dri
maldi
target
plate
sampl
analyz
ultraflextoftof
mass
spectromet
bruker
dalton
negativeion
reflect
mode
use
acceler
voltag
flexanalysi
softwar
use
gener
spectra
monosaccharid
composit
aliquot
column
eluat
hydrolyz
trifluoroacet
acid
convert
alditol
acet
analyz
use
gcm
perform
describ
previous
h
p
nmr
analysi
h
p
nmr
record
varian
nmr
analysi
ch
oh
eluat
perform
mg
materi
fraction
first
dri
glass
tube
stream
n
exchang
dri
reconstitut
l
prior
nmr
analysi
h
nmr
record
presat
mode
scan
p
nmr
record
scan
p
nmr
commerci
hmbpp
mg
l
also
record
scan
ap
assay
total
lipid
extract
chcl
ch
ohh
dri
resuspend
chcl
ch
oh
mixtur
centrifug
g
min
insolubl
materi
resuspend
h
filter
amicon
ultra
cutoff
mwco
iter
accumul
retent
eluat
substrat
alkalin
phosphatas
treatment
quantiti
retent
eluat
treat
u
ap
optizym
buffer
h
reaction
stop
incub
min
sham
reaction
includ
ap
without
substrat
either
retent
eluat
without
ap
dephosphoryl
sampl
exchang
evalu
p
nmr
thinlay
chromatographi
highperform
thinlay
chromatographi
sheet
emd
f
silica
gel
use
analyz
silica
column
fraction
appli
fraction
per
lane
develop
plate
chloroformmethanolwat
band
visual
spray
ninhydrin
dittmerlest
reagent
char
srm
assay
singlereact
monitor
srm
assay
develop
detect
quantif
hmbpp
use
water
xevo
tq
tripl
quadrapol
mass
spectromet
ms
electrospray
ioniz
coupl
water
acquiti
ultraperform
liquid
chromatographi
instrument
uplc
specif
materi
separ
use
zicphil
stationari
phase
merck
millipor
mm
decreas
gradient
acetonitril
gradient
follow
min
b
acetonitril
mm
ammonium
bicarbon
ph
adjust
ammonium
hydroxid
min
min
min
column
wash
lmin
b
min
equilibr
start
condit
column
volum
initi
solvent
condit
flow
rate
lmin
column
held
sampl
held
autosampl
inject
volum
l
mglp
inject
mgml
total
g
load
onto
column
neat
hmbppspike
inject
sourc
desolv
temperatur
respect
desolv
cone
collis
nebul
ga
flow
litersh
litersh
mlmin
pa
respect
ms
oper
select
reaction
monitor
mode
analysi
hmbpp
negativeion
mode
detect
parent
mz
hmbpp
follow
detect
abund
fragment
hmbpp
mz
argon
use
collis
ga
oper
flow
rate
mlmin
collisioninduc
reaction
mz
srm
transit
monitor
rang
low
ce
high
ce
collis
energi
collisioninduc
reaction
mz
six
srm
transit
monitor
rang
low
ce
high
ce
collis
energi
respons
transit
sum
transit
dwell
time
ms
collis
energi
cone
voltag
dwell
time
v
v
respect
capillari
voltag
kv
cell
stimulatori
activ
expand
cell
isol
pbmc
cultur
novel
antigen
fraction
control
medium
rest
pm
hmbpp
gml
mtbwl
live
bcg
multipl
infect
moi
day
pbmc
harvest
count
stain
tcr
tcr
absolut
number
cell
comput
multipli
flow
cytometr
percentag
number
viabl
cell
present
expans
expans
indic
ei
calcul
fold
expans
absolut
number
cell
stimul
treat
lysat
compar
absolut
number
cell
rest
medium
assay
cellmedi
inhibit
intracellular
mycobacteri
growth
experi
target
effector
cell
popul
prepar
previous
describ
briefli
pbmc
plate
obtain
macrophag
target
infect
bcg
moi
day
addit
cell
total
antigenexpand
pbmc
freshli
purifi
cell
ad
infect
macrophag
effectortotarget
cell
ratio
e
mediumrest
pbmc
well
ad
support
optim
intracellular
mycobacteri
growth
previous
describ
residu
intracellular
bcg
measur
incorpor
h
uridin
perkinelm
wallac
inc
boston
catalog
number
percentag
mycobacteri
growth
inhibit
determin
follow
percent
inhibit
dpm
presenc
cell
dpm
absenc
cell
dpm
disintegr
per
minut
effort
normal
data
appli
standard
quantifi
metric
specif
antimycobacteri
activ
cell
defin
specif
activ
sa
expans
index
percent
inhibit
intracellular
mycobacteri
growth
dri
weight
sampl
tcr
block
assay
modif
previous
publish
method
use
measur
agspecif
induct
intracellular
cytokin
product
analyz
tcr
depend
cell
activ
cell
expand
vitro
activ
mtbwl
mglp
hmbpp
healthi
purifi
protein
derivativeposit
ppd
donor
dendrit
cell
dc
infect
danish
strain
bcg
h
purifi
cell
cultur
bcginfect
uninfect
dc
antigenpres
cell
apc
cell
ratio
presenc
gml
bd
pharmingen
antitcr
clone
pierc
endogen
rockford
il
control
block
monoclon
antibodi
mab
r
system
minneapoli
mn
ad
purifi
cell
min
room
temperatur
cocultur
dc
h
stimul
lml
golgistop
bd
pharmingen
ad
cultur
incub
five
hour
cell
surfac
stain
tcr
fix
permeabil
cytofixcytoperm
bd
pharmingen
stain
detect
intracellular
gzma
analysi
facscalibur
flow
cytomet
minimum
event
acquir
analyz
use
cellquest
percentag
cell
respond
differ
antigen
defin
percentag
gzma
cell
stimul
block
assay
block
experi
isol
pbmc
cultur
novel
antigen
fraction
control
medium
rest
pm
hmbpp
gml
mtbwl
gml
mglpenrich
fraction
presenc
absenc
mab
gml
kindli
provid
daniel
oliv
inserm
marseil
day
day
phorbol
myrist
acet
pma
ionomycingolgistop
ad
cultur
incub
two
hour
cell
surfac
stain
tcr
fix
permeabil
cytofixcytoperm
bd
pharmingen
stain
detect
intracellular
gzma
analysi
facscalibur
flow
cytomet
minimum
event
acquir
analyz
use
cellquest
absolut
number
gzma
cell
comput
multipli
flow
cytometr
percentag
number
viabl
cell
present
expans
statist
analysi
statist
analys
experiment
data
employ
nonparametr
test
indic
perform
use
graphpad
prism
graphpad
softwar
san
diego
ca
unpair
pair
comparison
mannwhitney
u
test
wilcoxon
matchedpair
signedrank
test
appli
respect
mtbwl
induc
expans
protect
subset
cell
publish
result
demonstr
human
cell
circul
among
pbmc
obtain
ppdposit
individu
expand
inhibit
intracellular
mycobacteria
contrast
found
polycolon
cell
expand
ipp
phosphoantigen
unabl
inhibit
intracellular
mycobacteria
therefor
recent
screen
strategi
reveal
cell
antigen
focus
identif
tuberculosi
fraction
expand
cell
also
expand
cell
abil
inhibit
intracellular
mycobacteria
first
verifi
expans
protect
cell
requir
infect
host
cell
viabl
mycobacteria
compar
abil
mtbwlexpand
cell
live
bcgexpand
cell
inhibit
intracellular
mycobacteri
growth
similar
prepar
mtbwlexpand
live
bcgexpand
cell
produc
granzym
gzma
fig
b
importantli
mtbwlexpand
live
bcgexpand
cell
display
similar
function
capac
inhibit
intracellular
mycobacteri
growth
fig
result
clearli
demonstr
mtbwl
contain
antigen
capabl
induc
expans
protect
subset
cell
mycobacteri
compon
stimul
inhibitori
cell
proteas
resist
sensit
acid
hydrolysi
base
abovedescrib
result
initi
detail
biochem
work
character
antigen
mycobacteria
capabl
induc
optim
protect
tbspecif
cell
treat
mycobacteri
lysat
order
remov
larg
class
molecul
initi
biochem
treatment
consist
reduct
alkyl
disrupt
disulfid
bond
ii
delipid
via
organ
extract
chloroformmethanol
remov
nonpolar
lipid
iii
rnase
dnase
treatment
degrad
nucleotid
polym
iv
base
hydrolysi
cleav
baselabil
bond
v
mild
acid
hydrolysi
cleav
acid
labil
bond
vi
pronas
digest
extens
degrad
protein
vii
trypsin
digest
select
cleav
protein
complementari
approach
pronas
digest
fig
disrupt
disulfid
bond
stimulatori
antigen
signific
inhibitori
effect
induct
protect
cell
mtbwl
suggest
structur
unimport
biolog
activ
delipid
also
remov
biolog
activ
indic
tbspecif
cell
induc
antigen
consist
primarili
nonpolar
lipid
nucleas
treatment
affect
biolog
activ
lysat
indic
biolog
activ
requir
nucleotid
polym
greater
bp
length
howev
nucleas
treatment
would
elimin
nucleotid
conjug
discuss
previous
protein
digest
either
promiscu
pronas
select
trypsin
significantli
alter
biolog
activ
lysat
indic
antigen
interest
nonproteinac
proteinas
digest
cleav
protein
peptid
amino
acid
long
remain
larg
enough
load
onto
mhc
molecul
thu
two
proteinas
use
increas
likelihood
mhc
bind
motif
would
cleav
least
one
treatment
sinc
diminut
activ
detect
proteinas
treatment
conclud
antigen
protein
heavili
modifi
eg
glycosyl
inaccess
protein
digest
although
base
hydrolysi
hydrolyz
ester
oglycosyl
phosphodiest
bond
includ
inactiv
previous
identifi
phosphoantigen
ipp
hmbpp
etc
treatment
effect
biolog
activ
capabl
expand
inhibitori
cell
howev
mild
acid
hydrolysi
complet
elimin
stimulatori
capac
mycobacteri
lysat
tabl
fig
although
mild
acid
hydrolysi
destroy
sever
type
chemic
bond
treatment
use
would
expect
hydrolyz
complex
carbohydr
suggest
role
biolog
activ
data
consist
earlier
studi
demonstr
cellstimul
antigen
present
mycobacteri
extract
proteas
resist
bound
lectin
tbspecif
cell
subsequ
identif
strategi
involv
test
progress
purifi
tuberculosi
biochem
fraction
abil
expand
cell
inhibitori
activ
intracellular
mycobacteria
chloroformmethanolwat
extract
whole
tuberculosi
cell
found
retain
greatest
biolog
activ
result
extract
subsequ
load
onto
silica
gel
column
product
elut
increas
methanol
gradient
elut
fraction
test
abil
expand
inhibitori
cell
highest
biolog
sa
found
polar
fraction
elut
methanol
fig
meoh
fraction
analyz
tlc
stain
detect
carbohydr
ninhydrin
detect
peptid
dittmerlest
detect
phosphat
fig
crude
fraction
chcl
ch
ohh
start
materi
left
lane
furtherresolv
methanol
sampl
right
lane
demonstr
complex
initi
extract
partial
purif
success
achiev
downstream
meoh
fraction
consensu
analys
identifi
product
rich
hexos
residu
devoid
product
contain
amid
bond
peptid
phosphat
aromat
phenyl
residu
addit
nmr
spectra
reveal
signific
presenc
omethyl
group
anomer
proton
correspond
hexosyl
residu
fig
malditof
analysi
reveal
seri
highmolecularmass
product
amu
profil
similar
report
spectra
methylglucos
lipopolysaccharid
fig
c
malditof
data
directli
support
data
obtain
nmr
spectra
gcm
analys
alditol
acet
deriv
enrich
fraction
fig
gcm
analys
corrobor
nmr
find
identifi
highli
activ
fraction
order
achiev
enrich
mglp
estim
week
rest
medium
alon
expans
either
bcg
mtbwl
cell
identifi
stain
tcr
tcr
result
shown
gate
cell
vol
volunt
b
mtbwl
bcg
stimul
induc
similar
level
effector
molecul
pbmc
two
ppd
volunt
rest
medium
white
bar
stimul
gml
mycobacteri
lysat
stripe
bar
stimul
live
bcg
moi
black
bar
day
h
restimul
pma
ionomycin
golgistop
cell
stain
tcr
intracellular
granzym
analyz
flow
cytometri
c
mtbwl
induc
protect
cell
similar
live
bcg
infect
pbmc
cultur
vitro
bcg
mtbwl
medium
mr
alon
day
freshli
purifi
cell
cocultur
autolog
bcginfect
macrophag
e
bcg
viabil
determin
day
later
h
uridin
incorpor
bcgexpand
cell
mtbwlexpand
cell
significantli
inhibit
intracellular
mycobacteri
growth
compar
cultur
contain
mediumrest
cell
alon
gcm
fig
crude
ch
oh
fraction
methanol
fraction
dri
reconstitut
water
subject
size
exclus
sephadex
mwco
chromatographi
cell
expand
fraction
ml
elut
void
volum
column
glc
glc
ratio
found
exhibit
greatest
antimycobacteri
activ
fig
addit
result
fig
demonstr
mglp
fraction
induc
signific
prolif
expans
cell
cell
furthermor
fig
show
block
known
involv
phosphoantigen
activ
cell
also
inhibit
mglpinduc
cell
activ
determin
mglpenrich
fraction
induc
cell
tcrdepend
manner
simpli
via
innat
immun
activ
receptor
util
block
mab
known
inhibit
cell
respons
induc
ipp
hmbpp
biochem
treatment
consist
reduct
alkyl
disrupt
disulfid
bond
delipid
via
organ
extract
chloroformmethanol
remov
nonpolar
lipid
rnase
dnase
treatment
degrad
nucleotid
polym
base
hydrolysi
cleav
baselabil
bond
acid
hydrolysi
cleav
acidlabil
bond
pronas
digest
extens
degrad
protein
trypsin
digest
select
cleav
protein
complement
pronas
digest
treat
mycobacteri
lysat
test
abil
expand
cell
capabl
inhibit
intracellular
mycobacteria
expans
index
calcul
divid
absolut
number
cell
stimul
treat
lysat
absolut
number
cell
rest
medium
percent
inhibit
calcul
describ
previous
specif
activ
sa
defin
expans
index
percent
inhibit
intracellular
mycobacteri
growth
dri
weight
sampl
expans
index
sa
shown
panel
b
mycobacteri
antigen
stimul
inhibitori
cell
highli
sensit
acid
hydrolysi
result
confirm
mglp
fraction
contain
antigen
capabl
induc
tcrdepend
respons
fig
base
find
hypothes
lipopolysaccharid
deriv
similar
product
thereof
respons
biolog
activ
induc
mycobacteriuminhibitori
capac
cell
novel
mycobacteri
stimulatori
molecul
distinct
phosphoantigen
previous
identifi
small
antigen
known
stimul
cell
includ
phosphoryl
metabolit
gener
methyl
erythritol
pathway
mycobacteria
repres
stimulatori
molecul
isopentenyl
pyrophosph
ipp
e
pyrophosph
hmbpp
small
molecul
molecular
weight
respect
compos
one
isopren
unit
diphosh
attach
phosphat
group
ipp
sensit
termin
phosphatas
alkalin
phosphatas
apyras
novel
mycobacteri
antigen
activ
present
mglpenrich
fraction
could
abrog
treatment
alkalin
phosphatas
fig
result
suggest
cellstimul
bioactiv
present
novel
mglpenrich
mycobacteri
fraction
due
phosphoantigen
p
nmr
chemic
shift
detect
analysi
meoh
fraction
well
commerci
avail
highli
pure
hmbpp
shown
fig
methanol
fraction
show
spectral
peak
consist
hmbpp
spectra
support
conclus
biolog
potent
molecul
novel
mglpenrich
mtbwl
capabl
expand
protect
cell
induc
antigen
ipp
hmbpp
final
srm
ms
assay
develop
sensit
target
detect
hmbpp
assay
detect
level
hmbpp
picomolar
concentr
rang
known
activ
cell
applic
improv
chromatographi
use
ident
final
prepar
mglp
assay
greatli
improv
sensit
detect
expans
index
calcul
fold
expans
absolut
number
cell
stimul
treat
lysat
compar
absolut
number
cell
rest
medium
result
present
mean
se
b
percent
inhibit
calcul
describ
materi
method
result
present
mean
se
c
specif
activ
calcul
percent
inhibit
ei
dri
weight
materi
fig
supplement
materi
improv
sensit
confid
conclud
mglp
prepar
contamin
pm
concentr
hmbpp
least
less
requir
effici
cell
stimulatori
activ
hmbpp
detect
methanol
fraction
use
target
assay
confirm
fraction
enrich
phosphoantigen
fig
human
uniqu
cell
subpopul
term
cell
cell
express
cell
receptor
tcr
compris
chain
cell
exist
primat
human
nonhuman
repres
major
circul
cell
subset
typic
constitut
total
peripher
blood
cell
cell
provid
natur
bridg
innat
adapt
immun
rapidli
potent
respond
pathogen
infect
mucos
tissu
promin
induc
tb
infect
bcg
vaccin
therefor
cell
may
serv
potent
target
tb
immunotherapi
clinic
trial
use
variou
cell
activ
agent
aminobisphosphon
phosphoantigen
ongo
treatment
cancer
trial
report
low
toxic
improv
object
clinic
outcom
includ
stabil
partial
full
remiss
advancedstag
metastat
carcinoma
prostat
lung
kidney
therapeut
activ
cell
may
also
prove
benefici
numer
diseas
set
due
potent
adjuv
effector
function
innat
adapt
immun
data
recent
proofofcon
cept
studi
indic
expans
cell
vivo
pulmonari
tuberculosi
infect
limit
tuberculosi
replic
dissemin
attenu
tb
lesion
nonhuman
primat
report
previous
found
cell
expand
ipp
unabl
inhibit
intracellular
mycobacteria
result
suggest
differ
activ
induc
live
bcg
versu
ipp
respons
differ
inhibitori
effector
function
detail
followup
studi
fail
identifi
differ
effector
function
bcgand
ippexpand
cell
contrast
tcr
spectratyp
sequenc
analys
cell
line
expand
multipl
round
stimul
dendrit
cell
either
infect
live
bcg
puls
ipp
demonstr
tcr
sequenc
cell
expand
bcg
ipp
markedli
differ
bcgexpand
cell
subset
significantli
less
polyclon
ippexpand
cell
addit
bcgexpand
cell
univers
respons
ipp
small
fraction
total
ippexpand
cell
respons
bcg
similar
result
seen
cell
line
gener
ppd
individu
hundr
cell
clone
expand
singl
individu
furthermor
recent
identifi
hmbpp
phosphoantigen
potent
phosphoantigen
cell
express
tuberculosisand
bcginfect
macrophag
also
induc
cell
pathogeninhibitori
activ
overal
result
clearli
demonstr
bcgexpand
cell
repres
subset
ipprespons
cell
strongli
suggest
bcgexpand
cell
express
restrict
tcr
divers
capabl
recogn
uniqu
tuberculosi
antigen
express
infect
host
cell
distinct
previous
identifi
phosphoantigen
base
understand
one
goal
identifi
unknown
tuberculosi
antigen
capabl
stimul
cell
optim
tb
protect
capac
although
yet
abl
purifi
homogen
antigen
mycobacteria
stimul
relev
cultur
cell
harvest
irradi
lyophil
enrich
bioactiv
product
organ
extract
extract
load
onto
silica
gel
column
product
elut
meoh
fig
meoh
fraction
load
onto
column
elut
fraction
test
abil
expand
inhibitori
cell
note
increas
sa
carbohydraterich
fraction
column
fraction
compar
total
mtbwl
subsequ
fraction
mixtur
fraction
elut
column
b
mglp
mtbwl
induc
similar
level
cell
prolifer
respons
pbmc
two
ppd
volunt
rest
medium
white
bar
stimul
gml
mtbwl
stripe
bar
stimul
gml
mglpenrich
fraction
gray
bar
day
h
restimul
pma
ionomycin
golgistop
cell
stain
intracellular
granzym
analyz
flow
cytometri
c
block
known
involv
phosphoantigen
activ
cell
also
inhibit
mglpinduc
cell
activ
cell
cultur
day
medium
alon
gml
mtbwl
gml
mglpenrich
fraction
presenc
absenc
mab
gml
h
restimul
pma
ionomycin
golgistop
cell
stain
intracellular
granzym
analyz
flow
cytometri
absolut
number
gzma
cell
comput
multipli
flow
cytometr
percentag
time
number
viabl
cell
present
expans
cell
expand
mtbwl
mglpenrich
fraction
hmbpp
incub
bcginfect
uninfect
dc
h
total
lml
golgistop
bd
pharmingen
ad
cultur
incub
five
hour
gzma
product
detect
intracellular
cytokin
stain
cell
pretreat
antitcr
control
mab
min
cocultur
dc
respons
detect
percentag
gzma
cell
dc
stimul
result
one
repres
experi
three
perform
shown
cell
capabl
mediat
protect
effector
function
intracellular
mycobacteria
made
signific
progress
toward
goal
initi
step
prove
mtbwl
retain
capac
stimul
cell
mycobacteriuminhibitori
activ
observ
mild
acid
hydrolysi
mycobacteri
lysat
remov
inhibitori
cellstimulatori
activ
enrich
polar
lipid
extract
obtain
chloroformmethanolwat
separ
silica
column
product
elut
increas
gradient
methanol
product
elut
methanol
found
possess
highest
specif
activ
test
cell
expans
tuberculosi
growth
inhibit
assay
novel
fraction
analyz
tlc
use
ninhydrin
dittmerlest
stain
analyz
malditof
mass
spectrometri
gcm
nmr
consensu
analys
identifi
product
rich
omethylglucos
hexos
devoid
peptid
either
low
phosphat
phenyl
residu
includ
undetect
level
hmbpp
hmbpp
conjug
product
still
possibl
despit
ms
evid
contrari
especi
conjug
minor
product
detect
suppress
due
poor
ioniz
malditof
ms
analysi
reveal
seri
highmolecularmass
product
amu
profil
similar
report
spectra
methylglucos
lipopolysaccharid
analys
hypothes
lipopolysaccharid
mglp
deriv
similar
product
thereof
respons
expans
cell
mycobacteriuminhibitori
activ
mycobacteria
produc
two
cytoplasm
polymethyl
polysaccharid
mani
sugar
unit
partial
omethyl
polysaccharid
mmp
mglp
recent
evid
indic
least
two
cluster
gene
particip
mglp
biosynthesi
tuberculosi
one
cluster
encod
glucosyltransferas
respons
elong
mglp
well
put
acetyltransferas
two
put
methyltransferas
may
involv
branch
addit
second
cluster
encod
put
resuspend
chloroformmethanol
suspens
transfer
glass
tube
centrifug
chloroformmethanolinsolubl
materi
resuspend
water
filter
amicon
ultra
mwco
iter
obtain
retent
eluat
substrat
alkalin
phosphatas
ap
treatment
dephosphoryl
treatment
treat
fraction
test
abil
expand
cell
ei
cell
activ
fraction
tuberculosi
treat
alkalin
phosphatas
hydrolyz
phosphoryl
ester
still
retain
abil
expand
cell
b
differ
p
nmr
chemic
shift
meoh
fraction
commerci
hmbpp
blue
box
c
overlay
inject
seri
solvent
black
line
mglp
red
line
mglp
spike
pm
hmbpp
green
line
note
absenc
hmbpp
limit
detect
pm
resolv
retent
time
min
mglp
even
g
sampl
green
line
inject
onto
ms
instrument
minor
peak
repres
mglp
product
resolv
separ
hmbpp
chromatographi
mglp
x
axi
repres
retent
time
minut
axi
normal
percent
rel
abund
signal
sampl
base
total
peak
area
pm
hmbpp
sugarmodifi
enzym
includ
crucial
initi
mglp
biosynthesi
partial
compens
elong
mglp
inde
preliminari
analysi
extract
polar
lipid
mutant
versu
wildtyp
wt
tuberculosi
demonstr
reduct
presenc
matur
mglp
along
accumul
lowermass
product
amu
malditof
analysi
analysi
knockout
ko
wt
mglp
extract
cell
expans
demonstr
retent
activ
suggest
lowermass
variant
mglp
retain
biolog
activ
data
shown
support
role
possess
compensatori
enzymat
activ
limit
abil
use
knockout
studi
structur
requir
biolog
activ
compound
identifi
studi
mechanist
requir
antigen
recognit
cell
reveal
import
differ
tcr
cell
major
subset
human
peripher
blood
cell
express
tcr
heterodim
stimul
phosphoryl
metabolit
commonli
call
phosphoantigen
tcr
block
studi
indic
signal
tcr
requir
activ
cell
novel
mglpenrich
tuberculosi
stimulatori
molecul
addit
recent
studi
identifi
butyrophilin
key
molecul
involv
either
present
sens
phosphoantigen
necessari
stimul
cell
present
human
three
isoform
recent
studi
shown
antibodi
specif
could
either
mimic
phosphoantigenmedi
activ
tcr
antibodi
abrog
stimulatori
effect
antibodi
biophys
analysi
underli
interact
suggest
antibodi
induc
stabil
tcractiv
conform
addit
phosphoantigen
antibodi
activ
intracellular
signal
pathway
respond
cell
suggest
common
recognit
process
sandstrom
et
al
demonstr
act
intracellular
sensor
phosphoantigen
bind
phosphoantigen
surfac
pocket
locat
intracellular
domain
term
domain
result
confirm
structur
analysi
crystal
complex
mutat
analysi
present
work
provid
evid
novel
mglpenrich
tuberculosi
lipid
compon
also
requir
recognit
activ
cell
crucial
futur
studi
elucid
detail
mechan
involv
mglpmediat
activ
protect
cell
precis
involv
either
present
sens
mglp
stimulatori
molecul
summari
shown
ipp
hmbpp
expand
cell
incap
inhibit
intracellular
mycobacteria
human
studi
contrast
novel
polar
lipid
fraction
tuberculosi
enrich
glucos
polym
identifi
contain
potent
stimulatori
activ
tuberculosisinhibitori
cell
thu
mglp
deriv
may
repres
import
candid
immunotherapeut
treatment
drugsensit
resist
tuberculosi
infect
andor
use
novel
prophylact
tb
vaccin
approach
